Peripheral Vascular Stents Market Research Report 2017: Medical Devices Pipeline Assessment

“The Latest Research Report Peripheral Vascular Stents – Medical Devices Pipeline Assessment, 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. – MarketResearchReports.biz”

About Peripheral Vascular Stents Market

GlobalData’s Medical Devices sector report, Peripheral Vascular Stents – Medical Devices Pipeline Assessment, 2017″ provides an overview of Peripheral Vascular Stents currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Peripheral Vascular Stents pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

Get Sample copy of this Report @ https://www.marketresearchreports.biz/sample/sample/1339344

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

– Extensive coverage of the Peripheral Vascular Stents under development

– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

– The report reviews the major players involved in the development of Peripheral Vascular Stents and list all their pipeline projects

– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

– The report provides key clinical trial data of ongoing trials specific to pipeline products

– Recent developments in the segment / industry

Reasons to buy

The report enables you to –

– Formulate significant competitor information, analysis, and insights to improve R&D strategies

– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

– Identify and understand important and diverse types of Peripheral Vascular Stents under development

– Develop market-entry and market expansion strategies

– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

– In-depth analysis of the products current stage of development, territory and estimated launch date

View Sample PDF @ https://www.marketresearchreports.biz/reports/1339344/peripheral-vascular-stents-medical-devices-pipeline-assessment-2017-market-research-reports.pdf

Table of Contents

1 Table of Contents 2

1.1 List of Tables 6

1.2 List of Figures 11

2 Introduction 12

2.1 Peripheral Vascular Stents Overview 12

3 Products under Development 13

3.1 Peripheral Vascular Stents – Pipeline Products by Stage of Development 13

3.2 Peripheral Vascular Stents – Pipeline Products by Segment 14

3.3 Peripheral Vascular Stents – Pipeline Products by Territory 15

3.4 Peripheral Vascular Stents – Pipeline Products by Regulatory Path 16

3.5 Peripheral Vascular Stents – Pipeline Products by Estimated Approval Date 17

3.6 Peripheral Vascular Stents – Ongoing Clinical Trials 18

4 Peripheral Vascular Stents – Pipeline Products under Development by Companies 19

4.1 Peripheral Vascular Stents Companies – Pipeline Products by Stage of Development 19

4.2 Peripheral Vascular Stents – Pipeline Products by Stage of Development 21

5 Peripheral Vascular Stents Companies and Product Overview 24

5.1 3D Biotek LLC Company Overview 24

5.2 480 Biomedical Inc Company Overview 25

5.3 Abbott Vascular Inc Company Overview 29

5.4 AndraTec GmbH Company Overview 32

5.5 Biotronik SE & Co KG Company Overview 33

5.6 Boston Scientific Corp Company Overview 37

5.7 C. R. Bard Inc Company Overview 43

5.8 Cardiatis SA Company Overview 47

5.9 Cook Medical Inc Company Overview 48

5.10 Cordis Corp Company Overview 58

5.11 Corinnova Inc Company Overview 64

5.12 Cytograft Tissue Engineering Inc (Inactive) Company Overview 65

5.13 Efferent Labs Inc Company Overview 66

5.14 Electroformed Stents Inc Company Overview 67

5.15 Elixir Medical Corp Company Overview 69

5.16 Hexacath SA Company Overview 72

5.17 InspireMD Inc Company Overview 73

5.18 Intact Vascular LLC Company Overview 74

5.19 iVascular SLU Company Overview 79

5.20 Lifetech Scientific (Shenzhen) Co Ltd Company Overview 80

5.21 LimFlow GmbH Company Overview 82

5.22 Medinol Ltd Company Overview 85

Send An Enquiry Request @ https://www.marketresearchreports.biz/sample/enquiry/1339344

5.23 Micell Technologies Inc Company Overview 86

5.24 MicroVention Inc Company Overview 87

5.25 Natec Medical Ltd Company Overview 88

5.26 Nexeon MedSystems Inc Company Overview 89

5.27 Nipro Corp Company Overview 90

5.28 Northwestern University Company Overview 91

5.29 NSVascular, Inc. Company Overview 92

5.30 PeriTec Biosciences Ltd Company Overview 93

5.31 QualiMed Innovative Medizinprodukte GmbH Company Overview 95

5.32 Qvanteq AG Company Overview 98

5.33 REVA Medical Inc Company Overview 99

5.34 Stron Medical Company Overview 100

5.35 Synergy Flow Ltd Company Overview 101

5.36 Taewoong Medical Co Ltd Company Overview 102

5.37 Tepha Inc Company Overview 110

5.38 TissueGen Inc Company Overview 111

5.39 University of Michigan Company Overview 112

5.40 University of Pittsburgh Medical Center Company Overview 113

5.41 Vascular Bioresorbable Technologies Company Overview 114

5.42 Vascular Concepts Ltd Company Overview 116

5.43 Vascular Dynamics Ltd. Company Overview 119

5.44 Veniti Inc Company Overview 123

5.45 Veryan Medical Ltd Company Overview 126

5.46 VueKlar Cardiovascular Ltd Company Overview 130

5.47 Wake Forest University Health Sciences Company Overview 132

5.48 Xenogenics Corporation Company Overview 133

6 Peripheral Vascular Stents- Recent Developments 135

6.1 Sep 07, 2017: Abbott Named Industry Leader for Responsible and Sustainable Business for Five Consecutive Years on the Dow Jones Sustainability Index 135

6.2 Sep 01, 2017: Data Published in The Lancet Shows Positive Results at Primary Endpoint in the Treatment of Resistant Hypertension with MobiusHD Device 135

6.3 Aug 29, 2017: Abbott Issues New Updates for Implanted Cardiac Devices 136

6.4 Aug 28, 2017: Interim Data on MobiusHD Presented at the European Society of Cardiology Shows Promise in the Treatment of Resistant Hypertension 138

6.5 Aug 22, 2017: Vascular Dynamics, a Part of the Rainbow Medical Investment Cluster, Received FDA Approval to Begin Conclusive and Pivotal Trial Experimentation for Their Flagship Product Designed to Treat Chronic Hypertension 138

6.6 Aug 22, 2017: Getinge announces full U.S. availability of Pulsar-18 self-expanding stent from BIOTRONIK for patients with peripheral artery disease 139

6.7 Aug 22, 2017: Medtronic Reports First Quarter Financial Results 140

6.8 Aug 15, 2017: Vascular Dynamics Announces FDA Approval to Initiate CALM 2 Trial for MobiusHD System for the Treatment of Resistant Hypertension 143

6.9 Aug 10, 2017: Neovasc Announces Results for the Second Quarter of 2017 143

6.10 Aug 08, 2017: Inspire Reports Double Digit Sequential and Year-Over-Year Revenue Growth for the Second Quarter of 2017 147

6.11 Aug 08, 2017: InspireMD Reports Double Digit Sequential and Year-Over-Year Revenue Growth for the Second Quarter of 2017 148

6.12 Aug 01, 2017: LimFlow Announces Publication of Positive Results from Pilot Study of LimFlow Percutaneous Deep Vein Arterialization (pDVA) System 149

6.13 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017 150

6.14 Jul 26, 2017: Merit Medical Reports Record Revenue and Non-GAAP Net Income for Second Quarter 2017, Raises 2017 Guidance and Gives Preliminary 2018-2019 Guidance 152

6.15 Jul 26, 2017: CONMED Announces Second Quarter 2017 Financial Results 153

6.16 Jul 20, 2017: Abbott Reports Second-Quarter 2017 Results 154

6.17 Jul 18, 2017: Intact Vascular Announces Enrollment of First European Patient in Tack Optimized Balloon Angioplasty II Below the Knee (TOBA II BTK) Clinical Trial with the Tack Endovascular System 156

6.18 Jul 18, 2017: AngioDynamics Reports Fiscal 2017 Fourth Quarter and Full-Year Results 157

6.19 Jul 12, 2017: STENTYS: Revenues Of 1.7 Million in the Second Quarter Of 2017 159

6.20 Jul 11, 2017: LimFlow Announces First Patient Treated in U.S. Feasibility Study and Commencement of International Post-Market Study 160

6.21 Jul 10, 2017: FDA Approves 6-Month Primary Endpoint for the Tack Endovascular System in Below the Knee Disease 160

6.22 Jul 03, 2017: BIOTRONIK US Announces Pivotal Trial Results of the Pulsar-18 Stent with 4-French Delivery System 161

6.23 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day 162

6.24 Jun 06, 2017: LimFlow Expands Senior Management Team and Opens Silicon Valley Office 164

6.25 Jun 02, 2017: InspireMD Announces Appointment of Paul Stuka as Chairman of the Board 165

6.26 May 26, 2017: Merit Medical Announces Appointment of New Director 165

6.27 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results 166

6.28 May 15, 2017: Elixir Medical To Present Data on PRAVA Bioresorbable scaffold system at EuroPCR 2017 169

6.29 May 10, 2017: Neovasc Announces Results for the First Quarter of 2017 169

6.30 Apr 27, 2017: New Data Show Efficacy of Pulsar-18 Bare Metal Stent; Combination with Passeo-18 Lux DCB Challenges Results with Drug-Eluting Stents 171

6.31 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017 172

6.32 Apr 27, 2017: Merit Medical Reports Results for First Quarter of 2017 173

6.33 Apr 26, 2017: LimFlow Receives FDA Approval for U.S. Feasibility Study of Minimally-Invasive Technology Designed to Restore Perfusion in No Option Critical Limb Ischemia Patients 174

6.34 Apr 26, 2017: CONMED Announces First Quarter 2017 Financial Results 175

6.35 Apr 25, 2017: Edwards Lifesciences Reports First Quarter Results 176

6.36 Apr 24, 2017: STENTYS Reports a 22% Increase in Revenues in the First Quarter of 2017 177

6.37 Apr 23, 2017: Bard Announces First Quarter Results 178

6.38 Apr 21, 2017: Getinge launches the new Advanta V12 – 32mm Balloon Expandable Covered Stent 179

6.39 Apr 20, 2017: Lombard Medical Appoints New CEO 179

6.40 Apr 19, 2017: Abbott Reports First-Quarter 2017 Results 179

6.41 Apr 03, 2017: iVascular Receives CE Mark Approval for iVolution 200mm SX stent 182

6.42 Apr 03, 2017: STENTYS is Strengthening Its Board by Co-Opting Two New Independent Members 182

6.43 Mar 30, 2017: AngioDynamics Reports Fiscal 2017 Third Quarter Results 183

6.44 Mar 24, 2017: LifeTech Announces 2016 Annual Results 184

6.45 Mar 23, 2017: Intact Vascular Announces Completion Of Enrollment In The Tack Optimized Balloon Angioplasty II (Toba II) Clinical Trial 186

6.46 Mar 23, 2017: Neovasc Announces Results for the Fourth Quarter and Fiscal Year 2016 187

6.47 Mar 13, 2017: Cook Medical Announces Umesh Patel as President of Cook Biotech 190

6.48 Mar 10, 2017: Neovasc Announces TSX Symbol Change to NVCN 191

6.49 Mar 07, 2017: Anteo Technologies Announces Verification Study With Cook Medical Australia 191

6.50 Mar 06, 2017: GORE TIGRIS Vascular Stent Gains Health Canada Approval for Treatment of Peripheral Artery Disease 192

6.51 Mar 02, 2017: North Dallas Research Associates and Cardiac Center of Texas Begin Enrollment in TOBA II BTK Clinical Trial for New Peripheral Revascularization Treatment Option 193

6.52 Feb 27, 2017: TissueGen appoints new scientific advisory board member 193

6.53 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 194

6.54 Feb 21, 2017: Merit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2016 197

6.55 Feb 16, 2017: Medinol Announces Appointment Of Harvey J. Berger, M.D., As Executive Chairman Of Medinol US 198

6.56 Feb 16, 2017: InspireMD Provides Year End Business Update and Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2016 198

6.57 Feb 13, 2017: Intact Vascular’s Tack Optimized Balloon Angioplasty II Below The Knee (TOBA II BTK) Clinical Trial Commences Enrollment With First Implant Of The Tack Endovascular System 200

6.58 Feb 09, 2017: Terumo Announces Change of Executive Officers 200

6.59 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 202

6.60 Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016 202

6.61 Feb 01, 2017: Vascular Dynamics’ Announces Expedited Access Pathway Designation by FDA for MobiusHD to Accelerate US Access for Treatment of Resistant Hypertension 204

6.62 Feb 01, 2017: CONMED Announces Fourth Quarter and Fiscal Year 2016 Financial Results 205

6.63 Feb 01, 2017: Edwards Lifesciences Reports Fourth Quarter Results 206

6.64 Jan 31, 2017: Terumo Opens a Branch in Yangon 208

6.65 Jan 30, 2017: FDA Approves First Balloon Expandable Stent Graft For Use In The Iliac Artery 208

6.66 Jan 26, 2017: Bard Announces Fourth Quarter Results 209

6.67 Jan 18, 2017: Neovasc Announces Update in Litigation with CardiAQ 210

6.68 Jan 17, 2017: Intact Vasculars Tack Endovascular System Secures CE Mark for Repair of Dissections Following Angioplasty Below the Knee 210

6.69 Jan 12, 2017: STENTYS: 2016 Annual Revenues up 20% at 7.3 Million 211

6.70 Jan 06, 2017: AngioDynamics Reports Fiscal 2017 Second Quarter Results 211

6.71 Dec 12, 2016: Terumo Formulates 5-Year Mid- to Long-term Growth Strategy 213

6.72 Dec 08, 2016: Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference 213

6.73 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 215

6.74 Nov 21, 2016: VEITHsymposium 2016: BIOTRONIK Showcases Positive Results for Pulsar-18 Stent in the SFA 218

6.75 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 219

6.76 Nov 15, 2016: Final Patient Enrolled for Iliofemoral Venous Stent Study 219

6.77 Nov 15, 2016: LimFlow Receives CE Mark for Purely Percutaneous Critical Limb Ischemia Technology Designed to Restore Perfusion for No Option Patients 220

6.78 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 220

6.79 Nov 14, 2016: InspireMD Reports Financial Results for the Third Quarter Ended September 30, 2016 221

6.80 Nov 14, 2016: Neovasc Reports Third Quarter Results for 2016 223

6.81 Nov 09, 2016: AngioDynamics Announces Addition of New Board Members 226

6.82 Oct 31, 2016: FDA Approves TOBA II BTK Pivotal IDE Clinical Study 226

6.83 Oct 27, 2016: CONMED Announces Third Quarter 2016 Financial Results 227

6.84 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016 228

6.85 Oct 26, 2016: Merit Medical Reports Sales Up 15.3% for the Quarter Ended September 30, 2016 230

6.86 Oct 25, 2016: Edwards Lifesciences Reports Third Quarter Results 231

6.87 Oct 25, 2016: Bard Announces Third Quarter Results 233

6.88 Oct 24, 2016: Boston Scientific announced key Presentations on Eluvia Drug-Eluting Vascular Stent System at Transcatheter Cardiovascular Therapeutics 2016 233

6.89 Oct 20, 2016: Akesys Medical and Elixir Medical Announce First Human Implant of the PRAVA Bioresorbable Scaffold for Peripheral Vascular Disease 234

6.90 Oct 19, 2016: Abbott Reports Third-Quarter 2016 Results 235

6.91 Oct 18, 2016: LimFlow Names Daniel Rose as Chief Executive Officer 237

6.92 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer 238

6.93 Oct 05, 2016: AngioDynamics Reports Fiscal 2017 First Quarter Results 239

6.94 Sep 30, 2016: Pitt Team Receives $2.5 million in DOD Funds for First Retrievable Vascular Stent 240

6.95 Sep 30, 2016: Pitt Team Receives $2.5 million in DOD Funds for First Retrievable Vascular Stent 241

7 Appendix 242

7.1 Methodology 242

7.2 About GlobalData 245

7.3 Contact Us 245

7.4 Disclaimer 245

Buy Now This Report From Here @ https://www.researchmoz.com/checkout?rep_id=1339344&licType=S

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact

Mr. Nachiket

State Tower

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-621-2074

Website: http://www.marketresearchreports.biz/

E: sales@marketresearchreports.biz

Leave a Reply

Designed by CyFocus.com
Powered by CyFocus.net
%d bloggers like this: